Global Antisense Oligonucleotides Drugs for ATTR Supply, Demand and Key Producers, 2024-2030

Page: 83

Published Date: 13 Aug 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Antisense oligonucleotide(ASO)drugs represent a groundbreaking approach for treating transthyretin amyloidosis(ATTR),a condition characterized by the accumulation of misfolded transthyretin proteins that lead to organ damage.These ASO drugs work by targeting and degrading the mRNA that encodes for transthyretin,thus reducing its production at the source.

The global Antisense Oligonucleotides Drugs for ATTR market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Antisense Oligonucleotides Drugs for ATTR production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Antisense Oligonucleotides Drugs for ATTR and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antisense Oligonucleotides Drugs for ATTR that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Antisense Oligonucleotides Drugs for ATTR total production and demand, 2019-2030, (K Units)
Global Antisense Oligonucleotides Drugs for ATTR total production value, 2019-2030, (USD Million)
Global Antisense Oligonucleotides Drugs for ATTR production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Antisense Oligonucleotides Drugs for ATTR consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Antisense Oligonucleotides Drugs for ATTR domestic production, consumption, key domestic manufacturers and share
Global Antisense Oligonucleotides Drugs for ATTR production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Antisense Oligonucleotides Drugs for ATTR production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Antisense Oligonucleotides Drugs for ATTR production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Antisense Oligonucleotides Drugs for ATTR market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Akcea Therapeutics, AstraZeneca, Ionis Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antisense Oligonucleotides Drugs for ATTR market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Antisense Oligonucleotides Drugs for ATTR Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Antisense Oligonucleotides Drugs for ATTR Market, Segmentation by Type:
    Inotersen
    Eplontersen
    Other

Global Antisense Oligonucleotides Drugs for ATTR Market, Segmentation by Application:
    Hospital and Clinic
    Retail Pharmacies
    Other

Companies Profiled:
    Akcea Therapeutics
    AstraZeneca
    Ionis Pharmaceuticals

Key Questions Answered:
1. How big is the global Antisense Oligonucleotides Drugs for ATTR market?
2. What is the demand of the global Antisense Oligonucleotides Drugs for ATTR market?
3. What is the year over year growth of the global Antisense Oligonucleotides Drugs for ATTR market?
4. What is the production and production value of the global Antisense Oligonucleotides Drugs for ATTR market?
5. Who are the key producers in the global Antisense Oligonucleotides Drugs for ATTR market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Antisense Oligonucleotides Drugs for ATTR Introduction
    1.2 World Antisense Oligonucleotides Drugs for ATTR Supply & Forecast
        1.2.1 World Antisense Oligonucleotides Drugs for ATTR Production Value (2019 & 2023 & 2030)
        1.2.2 World Antisense Oligonucleotides Drugs for ATTR Production (2019-2030)
        1.2.3 World Antisense Oligonucleotides Drugs for ATTR Pricing Trends (2019-2030)
    1.3 World Antisense Oligonucleotides Drugs for ATTR Production by Region (Based on Production Site)
        1.3.1 World Antisense Oligonucleotides Drugs for ATTR Production Value by Region (2019-2030)
        1.3.2 World Antisense Oligonucleotides Drugs for ATTR Production by Region (2019-2030)
        1.3.3 World Antisense Oligonucleotides Drugs for ATTR Average Price by Region (2019-2030)
        1.3.4 North America Antisense Oligonucleotides Drugs for ATTR Production (2019-2030)
        1.3.5 Europe Antisense Oligonucleotides Drugs for ATTR Production (2019-2030)
        1.3.6 China Antisense Oligonucleotides Drugs for ATTR Production (2019-2030)
        1.3.7 Japan Antisense Oligonucleotides Drugs for ATTR Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Antisense Oligonucleotides Drugs for ATTR Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Antisense Oligonucleotides Drugs for ATTR Major Market Trends

2 Demand Summary
    2.1 World Antisense Oligonucleotides Drugs for ATTR Demand (2019-2030)
    2.2 World Antisense Oligonucleotides Drugs for ATTR Consumption by Region
        2.2.1 World Antisense Oligonucleotides Drugs for ATTR Consumption by Region (2019-2024)
        2.2.2 World Antisense Oligonucleotides Drugs for ATTR Consumption Forecast by Region (2025-2030)
    2.3 United States Antisense Oligonucleotides Drugs for ATTR Consumption (2019-2030)
    2.4 China Antisense Oligonucleotides Drugs for ATTR Consumption (2019-2030)
    2.5 Europe Antisense Oligonucleotides Drugs for ATTR Consumption (2019-2030)
    2.6 Japan Antisense Oligonucleotides Drugs for ATTR Consumption (2019-2030)
    2.7 South Korea Antisense Oligonucleotides Drugs for ATTR Consumption (2019-2030)
    2.8 ASEAN Antisense Oligonucleotides Drugs for ATTR Consumption (2019-2030)
    2.9 India Antisense Oligonucleotides Drugs for ATTR Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Antisense Oligonucleotides Drugs for ATTR Production Value by Manufacturer (2019-2024)
    3.2 World Antisense Oligonucleotides Drugs for ATTR Production by Manufacturer (2019-2024)
    3.3 World Antisense Oligonucleotides Drugs for ATTR Average Price by Manufacturer (2019-2024)
    3.4 Antisense Oligonucleotides Drugs for ATTR Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Antisense Oligonucleotides Drugs for ATTR Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Antisense Oligonucleotides Drugs for ATTR in 2023
        3.5.3 Global Concentration Ratios (CR8) for Antisense Oligonucleotides Drugs for ATTR in 2023
    3.6 Antisense Oligonucleotides Drugs for ATTR Market: Overall Company Footprint Analysis
        3.6.1 Antisense Oligonucleotides Drugs for ATTR Market: Region Footprint
        3.6.2 Antisense Oligonucleotides Drugs for ATTR Market: Company Product Type Footprint
        3.6.3 Antisense Oligonucleotides Drugs for ATTR Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Antisense Oligonucleotides Drugs for ATTR Production Value Comparison
        4.1.1 United States VS China: Antisense Oligonucleotides Drugs for ATTR Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Antisense Oligonucleotides Drugs for ATTR Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Antisense Oligonucleotides Drugs for ATTR Production Comparison
        4.2.1 United States VS China: Antisense Oligonucleotides Drugs for ATTR Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Antisense Oligonucleotides Drugs for ATTR Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Antisense Oligonucleotides Drugs for ATTR Consumption Comparison
        4.3.1 United States VS China: Antisense Oligonucleotides Drugs for ATTR Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Antisense Oligonucleotides Drugs for ATTR Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Antisense Oligonucleotides Drugs for ATTR Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Antisense Oligonucleotides Drugs for ATTR Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production (2019-2024)
    4.5 China Based Antisense Oligonucleotides Drugs for ATTR Manufacturers and Market Share
        4.5.1 China Based Antisense Oligonucleotides Drugs for ATTR Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production Value (2019-2024)
        4.5.3 China Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production (2019-2024)
    4.6 Rest of World Based Antisense Oligonucleotides Drugs for ATTR Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Antisense Oligonucleotides Drugs for ATTR Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production (2019-2024)

5 Market Analysis by Type
    5.1 World Antisense Oligonucleotides Drugs for ATTR Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Inotersen
        5.2.2 Eplontersen
        5.2.3 Other
    5.3 Market Segment by Type
        5.3.1 World Antisense Oligonucleotides Drugs for ATTR Production by Type (2019-2030)
        5.3.2 World Antisense Oligonucleotides Drugs for ATTR Production Value by Type (2019-2030)
        5.3.3 World Antisense Oligonucleotides Drugs for ATTR Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Antisense Oligonucleotides Drugs for ATTR Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital and Clinic
        6.2.2 Retail Pharmacies
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Antisense Oligonucleotides Drugs for ATTR Production by Application (2019-2030)
        6.3.2 World Antisense Oligonucleotides Drugs for ATTR Production Value by Application (2019-2030)
        6.3.3 World Antisense Oligonucleotides Drugs for ATTR Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Akcea Therapeutics
        7.1.1 Akcea Therapeutics Details
        7.1.2 Akcea Therapeutics Major Business
        7.1.3 Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Product and Services
        7.1.4 Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Akcea Therapeutics Recent Developments/Updates
        7.1.6 Akcea Therapeutics Competitive Strengths & Weaknesses
    7.2 AstraZeneca
        7.2.1 AstraZeneca Details
        7.2.2 AstraZeneca Major Business
        7.2.3 AstraZeneca Antisense Oligonucleotides Drugs for ATTR Product and Services
        7.2.4 AstraZeneca Antisense Oligonucleotides Drugs for ATTR Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 AstraZeneca Recent Developments/Updates
        7.2.6 AstraZeneca Competitive Strengths & Weaknesses
    7.3 Ionis Pharmaceuticals
        7.3.1 Ionis Pharmaceuticals Details
        7.3.2 Ionis Pharmaceuticals Major Business
        7.3.3 Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Product and Services
        7.3.4 Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Ionis Pharmaceuticals Recent Developments/Updates
        7.3.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Antisense Oligonucleotides Drugs for ATTR Industry Chain
    8.2 Antisense Oligonucleotides Drugs for ATTR Upstream Analysis
        8.2.1 Antisense Oligonucleotides Drugs for ATTR Core Raw Materials
        8.2.2 Main Manufacturers of Antisense Oligonucleotides Drugs for ATTR Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Antisense Oligonucleotides Drugs for ATTR Production Mode
    8.6 Antisense Oligonucleotides Drugs for ATTR Procurement Model
    8.7 Antisense Oligonucleotides Drugs for ATTR Industry Sales Model and Sales Channels
        8.7.1 Antisense Oligonucleotides Drugs for ATTR Sales Model
        8.7.2 Antisense Oligonucleotides Drugs for ATTR Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Antisense Oligonucleotides Drugs for ATTR Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Antisense Oligonucleotides Drugs for ATTR Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Antisense Oligonucleotides Drugs for ATTR Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Antisense Oligonucleotides Drugs for ATTR Production Value Market Share by Region (2019-2024)
 Table 5. World Antisense Oligonucleotides Drugs for ATTR Production Value Market Share by Region (2025-2030)
 Table 6. World Antisense Oligonucleotides Drugs for ATTR Production by Region (2019-2024) & (K Units)
 Table 7. World Antisense Oligonucleotides Drugs for ATTR Production by Region (2025-2030) & (K Units)
 Table 8. World Antisense Oligonucleotides Drugs for ATTR Production Market Share by Region (2019-2024)
 Table 9. World Antisense Oligonucleotides Drugs for ATTR Production Market Share by Region (2025-2030)
 Table 10. World Antisense Oligonucleotides Drugs for ATTR Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Antisense Oligonucleotides Drugs for ATTR Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Antisense Oligonucleotides Drugs for ATTR Major Market Trends
 Table 13. World Antisense Oligonucleotides Drugs for ATTR Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World Antisense Oligonucleotides Drugs for ATTR Consumption by Region (2019-2024) & (K Units)
 Table 15. World Antisense Oligonucleotides Drugs for ATTR Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World Antisense Oligonucleotides Drugs for ATTR Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Antisense Oligonucleotides Drugs for ATTR Producers in 2023
 Table 18. World Antisense Oligonucleotides Drugs for ATTR Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key Antisense Oligonucleotides Drugs for ATTR Producers in 2023
 Table 20. World Antisense Oligonucleotides Drugs for ATTR Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Antisense Oligonucleotides Drugs for ATTR Company Evaluation Quadrant
 Table 22. World Antisense Oligonucleotides Drugs for ATTR Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Antisense Oligonucleotides Drugs for ATTR Production Site of Key Manufacturer
 Table 24. Antisense Oligonucleotides Drugs for ATTR Market: Company Product Type Footprint
 Table 25. Antisense Oligonucleotides Drugs for ATTR Market: Company Product Application Footprint
 Table 26. Antisense Oligonucleotides Drugs for ATTR Competitive Factors
 Table 27. Antisense Oligonucleotides Drugs for ATTR New Entrant and Capacity Expansion Plans
 Table 28. Antisense Oligonucleotides Drugs for ATTR Mergers & Acquisitions Activity
 Table 29. United States VS China Antisense Oligonucleotides Drugs for ATTR Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Antisense Oligonucleotides Drugs for ATTR Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China Antisense Oligonucleotides Drugs for ATTR Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based Antisense Oligonucleotides Drugs for ATTR Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production Market Share (2019-2024)
 Table 37. China Based Antisense Oligonucleotides Drugs for ATTR Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production Market Share (2019-2024)
 Table 42. Rest of World Based Antisense Oligonucleotides Drugs for ATTR Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production Market Share (2019-2024)
 Table 47. World Antisense Oligonucleotides Drugs for ATTR Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Antisense Oligonucleotides Drugs for ATTR Production by Type (2019-2024) & (K Units)
 Table 49. World Antisense Oligonucleotides Drugs for ATTR Production by Type (2025-2030) & (K Units)
 Table 50. World Antisense Oligonucleotides Drugs for ATTR Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Antisense Oligonucleotides Drugs for ATTR Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Antisense Oligonucleotides Drugs for ATTR Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Antisense Oligonucleotides Drugs for ATTR Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Antisense Oligonucleotides Drugs for ATTR Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Antisense Oligonucleotides Drugs for ATTR Production by Application (2019-2024) & (K Units)
 Table 56. World Antisense Oligonucleotides Drugs for ATTR Production by Application (2025-2030) & (K Units)
 Table 57. World Antisense Oligonucleotides Drugs for ATTR Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Antisense Oligonucleotides Drugs for ATTR Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Antisense Oligonucleotides Drugs for ATTR Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Antisense Oligonucleotides Drugs for ATTR Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Akcea Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 62. Akcea Therapeutics Major Business
 Table 63. Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Product and Services
 Table 64. Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Akcea Therapeutics Recent Developments/Updates
 Table 66. Akcea Therapeutics Competitive Strengths & Weaknesses
 Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
 Table 68. AstraZeneca Major Business
 Table 69. AstraZeneca Antisense Oligonucleotides Drugs for ATTR Product and Services
 Table 70. AstraZeneca Antisense Oligonucleotides Drugs for ATTR Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. AstraZeneca Recent Developments/Updates
 Table 72. AstraZeneca Competitive Strengths & Weaknesses
 Table 73. Ionis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 74. Ionis Pharmaceuticals Major Business
 Table 75. Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Product and Services
 Table 76. Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Ionis Pharmaceuticals Recent Developments/Updates
 Table 78. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
 Table 79. Global Key Players of Antisense Oligonucleotides Drugs for ATTR Upstream (Raw Materials)
 Table 80. Global Antisense Oligonucleotides Drugs for ATTR Typical Customers
 Table 81. Antisense Oligonucleotides Drugs for ATTR Typical Distributors


List of Figures
 Figure 1. Antisense Oligonucleotides Drugs for ATTR Picture
 Figure 2. World Antisense Oligonucleotides Drugs for ATTR Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Antisense Oligonucleotides Drugs for ATTR Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Antisense Oligonucleotides Drugs for ATTR Production (2019-2030) & (K Units)
 Figure 5. World Antisense Oligonucleotides Drugs for ATTR Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Antisense Oligonucleotides Drugs for ATTR Production Value Market Share by Region (2019-2030)
 Figure 7. World Antisense Oligonucleotides Drugs for ATTR Production Market Share by Region (2019-2030)
 Figure 8. North America Antisense Oligonucleotides Drugs for ATTR Production (2019-2030) & (K Units)
 Figure 9. Europe Antisense Oligonucleotides Drugs for ATTR Production (2019-2030) & (K Units)
 Figure 10. China Antisense Oligonucleotides Drugs for ATTR Production (2019-2030) & (K Units)
 Figure 11. Japan Antisense Oligonucleotides Drugs for ATTR Production (2019-2030) & (K Units)
 Figure 12. Antisense Oligonucleotides Drugs for ATTR Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Antisense Oligonucleotides Drugs for ATTR Consumption (2019-2030) & (K Units)
 Figure 15. World Antisense Oligonucleotides Drugs for ATTR Consumption Market Share by Region (2019-2030)
 Figure 16. United States Antisense Oligonucleotides Drugs for ATTR Consumption (2019-2030) & (K Units)
 Figure 17. China Antisense Oligonucleotides Drugs for ATTR Consumption (2019-2030) & (K Units)
 Figure 18. Europe Antisense Oligonucleotides Drugs for ATTR Consumption (2019-2030) & (K Units)
 Figure 19. Japan Antisense Oligonucleotides Drugs for ATTR Consumption (2019-2030) & (K Units)
 Figure 20. South Korea Antisense Oligonucleotides Drugs for ATTR Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN Antisense Oligonucleotides Drugs for ATTR Consumption (2019-2030) & (K Units)
 Figure 22. India Antisense Oligonucleotides Drugs for ATTR Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of Antisense Oligonucleotides Drugs for ATTR by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Antisense Oligonucleotides Drugs for ATTR Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Antisense Oligonucleotides Drugs for ATTR Markets in 2023
 Figure 26. United States VS China: Antisense Oligonucleotides Drugs for ATTR Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Antisense Oligonucleotides Drugs for ATTR Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Antisense Oligonucleotides Drugs for ATTR Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production Market Share 2023
 Figure 30. China Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Antisense Oligonucleotides Drugs for ATTR Production Market Share 2023
 Figure 32. World Antisense Oligonucleotides Drugs for ATTR Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Antisense Oligonucleotides Drugs for ATTR Production Value Market Share by Type in 2023
 Figure 34. Inotersen
 Figure 35. Eplontersen
 Figure 36. Other
 Figure 37. World Antisense Oligonucleotides Drugs for ATTR Production Market Share by Type (2019-2030)
 Figure 38. World Antisense Oligonucleotides Drugs for ATTR Production Value Market Share by Type (2019-2030)
 Figure 39. World Antisense Oligonucleotides Drugs for ATTR Average Price by Type (2019-2030) & (US$/Unit)
 Figure 40. World Antisense Oligonucleotides Drugs for ATTR Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 41. World Antisense Oligonucleotides Drugs for ATTR Production Value Market Share by Application in 2023
 Figure 42. Hospital and Clinic
 Figure 43. Retail Pharmacies
 Figure 44. Other
 Figure 45. World Antisense Oligonucleotides Drugs for ATTR Production Market Share by Application (2019-2030)
 Figure 46. World Antisense Oligonucleotides Drugs for ATTR Production Value Market Share by Application (2019-2030)
 Figure 47. World Antisense Oligonucleotides Drugs for ATTR Average Price by Application (2019-2030) & (US$/Unit)
 Figure 48. Antisense Oligonucleotides Drugs for ATTR Industry Chain
 Figure 49. Antisense Oligonucleotides Drugs for ATTR Procurement Model
 Figure 50. Antisense Oligonucleotides Drugs for ATTR Sales Model
 Figure 51. Antisense Oligonucleotides Drugs for ATTR Sales Channels, Direct Sales, and Distribution
 Figure 52. Methodology
 Figure 53. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Akcea Therapeutics
AstraZeneca
Ionis Pharmaceuticals

Related Reports

Global Antisense Oligonucleotides Drugs for ATTR Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Antisense Oligonucleotides Drugs for ATTR Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 13 Aug 2024

date Pharma & Healthcare

Antisense oligonucleotide(ASO)drugs represent a groundbreaking approach for treating transthyretin amyloidosis(ATTR),a condition characterized by the accumulation of misfolded transthyretin proteins that lead to organ damage.These ASO drugs work by targeting and degrading the mRNA that encodes for transthyretin,thus reducing its production at the source.

Product Tags

Antisense Oligonucleotides Drugs for ATTR

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>